• Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Search
  • Who we are
  • How to use and read
Pharma World
  • Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Home Tags Reshoring

Tag: reshoring

Hungary: Logistic challenges in the pharma industry due to Covid-19

Giuliana Miglierini - 18 December 2020
0

Recent Posts

  • EIPG: Q&A follow up webinar session on MDR – Joint Statement on future modifications to the Directive on the RPQ for Pharmacists
  • Human and veterinary medicines: EMA’s highlights of 2020
  • The socio-economic impact of IMI1 projects
  • ICH’s reflection paper and consultation on patient focused drug development
  • A report on the impact of biosimilar competition in Europe

Latest Updates

  • 2018/04 - December

    2018/04 – December

  • 2018/03 – November

  • 2018/02 – June

  • 2018/01 – May

Subscribe to our newsletter

Translate

NCF – Notiziario Chimico Farmaceutico

RSS NCF

  • Imaging biomedicale, una guida alla scelta delle telecamere di machine vision
  • Farmaci Serm, una possibile nuova arma contro SARS-CoV-2
  • Semaglutide per sconfiggere il sovrappeso
  • Roche, ricavi in aumento grazie al test per la diagnosi di Covid-19
  • EMA, Janssen chiede l’autorizzazione per il suo candidato vaccino
© 2020 Tecniche Nuove Spa • Tutti i diritti riservati. Sede legale: Via Eritrea 21 - 20157 Milano. Capitale sociale: 5.000.000 euro interamente versati. Codice fiscale, Partita Iva e Iscrizione al Registro delle Imprese di Milano: 00753480151